Possibility of genetic therapy for inherited retinal conditions

Gilbert, 1994, Causes of blindness and severe visual impairment in children in Chile, Dev Med Child Neurol., 36, 326, 10.1111/j.1469-8749.1994.tb11853.x Singh, 2018, Genes and genetics in eye diseases: a genomic medicine approach for investigating hereditary and inflammatory ocular disorders, Int J Ophthalmol., 11, 117 Daiger Amato, 2021, Gene therapy in inherited retinal diseases: an update on current state of the art, Front Med (Lausanne)., 8 Zhou, 2010, Ocular immune privilege, F1000 Biol Rep., 2, 3, 10.3410/B2-3 Moraru, 2022, Current trends in gene therapy for retinal diseases (Review), Exp Ther Med., 23, 26, 10.3892/etm.2021.10948 Richards, 2015, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med., 17, 405, 10.1038/gim.2015.30 Zanolli, 2020, Genetic testing for inherited ocular conditions in a developing country, Ophthalmic Genet., 41, 36, 10.1080/13816810.2020.1734944 Le Meur, 2018, Safety and long-term efficacy of AAV4 gene therapy in patients with RPE65 Leber congenital amaurosis, Mol Ther., 26, 256, 10.1016/j.ymthe.2017.09.014 Capasso, 2014, The cost of genetic testing for ocular disease: who pays?, Curr Opin Ophthalmol., 25, 394, 10.1097/ICU.0000000000000085 Mashima, 2017, Visual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation, BMC Ophthalmol., 17, 192, 10.1186/s12886-017-0583-3 Singh, 2018, Genes and genetics in eye diseases: a genomic medicine approach for investigating hereditary and inflammatory ocular disorders, Int J Ophthalmol., 11, 117 Lee, 2019, Gene therapy for visual loss: opportunities and concerns, Prog Retin Eye Res., 68, 31, 10.1016/j.preteyeres.2018.08.003 Boon, 2020, Research models and gene augmentation therapy for CRB1 retinal dystrophies, Front Neurosci., 14, 860, 10.3389/fnins.2020.00860 Greenwald, 2020, Gene therapy preserves retinal structure and function in a mouse model of NMNAT1-associated retinal degeneration, Mol Ther Methods Clin Dev., 18, 582, 10.1016/j.omtm.2020.07.003 Feathers, 2019, Development of a gene therapy vector for RDH12-associated retinal dystrophy, Hum Gene Ther., 30, 1325, 10.1089/hum.2019.017 Uyhazi, 2020, Treatment potential for LCA5-associated Leber congenital amaurosis, Invest Ophthalmol Vis Sci., 61, 30, 10.1167/iovs.61.5.30 Bonifert, 2016, Antisense oligonucleotide mediated splice correction of a deep intronic mutation in OPA1, Mol Ther Nucleic Acids., 5, e390, 10.1038/mtna.2016.93 Guziewicz, 2018, BEST1 gene therapy corrects a diffuse retina-wide microdetachment modulated by light exposure, Proc Natl Acad Sci USA., 115, E2839, 10.1073/pnas.1720662115